Medical Innovation Exchange

Genfit revs up liver failure strategy with $41M biotech buyout, bagging phase 2-ready candidate

https://www.fiercebiotech.com/biotech/genfit-revs-liver-failure-strategy-41m-biotech-buyout-bagging-phase-2-ready-candidate

Leave a Comment

Your email address will not be published.

Leave the field below empty!